Bio-Rad Laboratories, Inc. BIO.B Total Cost of Revenue
Total Cost of Revenue at other companies
Segments
By segment
See fullOther financials
Where this comes from
Reported directly by Bio-Rad Laboratories, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The official record: Bio-Rad Laboratories, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories, Inc.'s total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Rad Laboratories, Inc.'s total cost of revenue?
- Bio-Rad Laboratories, Inc. (BIO.B) reported total cost of revenue of $282.7M in Q1 2026.
- How has Bio-Rad Laboratories, Inc.'s total cost of revenue changed year-over-year?
- Bio-Rad Laboratories, Inc.'s total cost of revenue increased by 1.2% year-over-year, from $279.4M to $282.7M.
- What is the long-term trend for Bio-Rad Laboratories, Inc.'s total cost of revenue?
- Over 4 years (2021 to 2025), Bio-Rad Laboratories, Inc.'s total cost of revenue has grown at a -0.8% compound annual growth rate (CAGR), from $1.28B to $1.24B.
- What does total cost of revenue mean?
- Total cost of revenue includes the direct costs attributable to the production of the goods sold or services provided by the company. This encompasses raw materials, direct labor, and manufacturing overhead. It is a critical component in determining the efficiency of the production process.